Grant C. Bogle - 18 Jun 2025 Form 4 Insider Report for Nuvalent, Inc. (NUVL)

Reporting relationship: Director
Issuer ticker: NUVL
Reported as of: 18 Jun 2025
Net transaction value: $0
SEC form: 4
Accepted by SEC: 20 Jun 2025, 16:33:47 UTC
Prior SEC filing: 09 Dec 2024
Next SEC filing: 18 Jun 2026
Source filing: View source filing
Reporting owner signature: /s/ Nathan McConarty, attorney-in-fact

Key filing fact

Grant C. Bogle filed Form 4 for Nuvalent, Inc. (NUVL) on 20 Jun 2025.

Key facts

This page summarizes Grant C. Bogle's Form 4 filing for Nuvalent, Inc. (NUVL).
2 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 20 Jun 2025, 16:33.

Change

Previous filing in this sequence was filed on 09 Dec 2024.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001646675 Primary reporting owner

Bogle Grant C.

Relationship: Director
Address: C/O NUVALENT, INC., ONE BROADWAY, 14TH FLOOR, CAMBRIDGE
Signature: /s/ Nathan McConarty, attorney-in-fact
Signature date: 20 Jun 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

NUVL transaction

Class A Common Stock

Award

Transaction value: $0
Shares: +2,647
Change %: +83%
Price: $0.000000
Shares after: 5,847
Date: 18 Jun 2025
Ownership: Direct
Footnotes: F1

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

NUVL transaction Derivative

Stock Option (Right to Buy)

Award

Transaction value: $0
Shares: +4,147
Change %
Price: $0.000000
Shares after: 4,147
Date: 18 Jun 2025
Ownership: Direct
Underlying class: Class A Common Stock
Underlying amount: 4,147
Exercise price: $75.53
Footnotes: F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Consists of shares of Nuvalent, Inc. Class A Common Stock issuable under restricted stock units ("RSUs"). Each RSU represents the right to receive one share of Nuvalent, Inc. Class A Common Stock. The RSUs vest in full on the earlier of June 18, 2026 or the date of Nuvalent, Inc.'s next annual meeting of stockholders, subject to continued service to Nuvalent, Inc. through the applicable vesting date.

Footnote F2

The shares underlying this option vest in full on the earlier of June 18, 2026 or the date of Nuvalent, Inc.'s next annual meeting of stockholders, subject to continued service to Nuvalent, Inc. through the applicable vesting date.